Promega to Develop Microsatellite Instability (MSI) Companion Diagnostic IVD Kit in Collaboration With GSK

Promega to Develop Microsatellite Instability (MSI) Companion Diagnostic IVD Kit in Collaboration With GSK –Promega Corporation today announced it plans to develop and commercialize a microsatellite instability (MSI) companion diagnostic (CDx)…

Read MorePromega to Develop Microsatellite Instability (MSI) Companion Diagnostic IVD Kit in Collaboration With GSK

Sphere Fluidics’ Cyto-Mine System Selected by FairJourney Biologics to Advance Cell Line Development Workflows

Sphere Fluidics’ Cyto-Mine System Selected by FairJourney Biologics to Advance Cell Line Development Workflows Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, today…

Read MoreSphere Fluidics’ Cyto-Mine System Selected by FairJourney Biologics to Advance Cell Line Development Workflows

Automata Technologies: $40m fundraise backed by Dimension and A.P. Moller Holding, to expand growing life science lab automation offering

Automata Technologies: $40m fundraise backed by Dimension and A.P. Moller Holding, to expand growing life science lab automation offering –Automata Technologies, a leading automation company powering life sciences labs, has raised…

Read MoreAutomata Technologies: $40m fundraise backed by Dimension and A.P. Moller Holding, to expand growing life science lab automation offering

ew Analysis Highlights Importance of Adhering to Uninterrupted Full Course of Treatment with TEPEZZAto Support Thyroid Eye Disease Patient Outcomes

ew Analysis Highlights Importance of Adhering to Uninterrupted Full Course of Treatment with TEPEZZA® (teprotumumab-trbw) to Support Thyroid Eye Disease (TED) Patient Outcomes Horizon Therapeutics plc (Nasdaq: HZNP) today announced new…

Read Moreew Analysis Highlights Importance of Adhering to Uninterrupted Full Course of Treatment with TEPEZZAto Support Thyroid Eye Disease Patient Outcomes